Skip to content

Fellow Publications

Listed are some of the abstracts and publications our most recent fellows have completed during their time in the program:

Andrew Fintel
Wiedower, Giri, Fintel, Prouet, Paulus, Chandler, Martin. Addition of rituximab to chemotherapy decreased mortality rates of primary surgery for gastric DLBCL without increasing early mortality. Presentation ASH – Annual Meeting 12/4/2015
Benny Johnson

Mahadevan, D., Johnson, N., Johnson, B., Pandey, P., Chandler, J., Cooke, L.  Novel mutational profiles in relapsed/refractory advanced cancer patients' pre- and post-targeted therapy.  Presentation at Mayo Clinic 7/30/15.

Johnson, B., Giri S., Nunnery S., Wiedower E., Jamy O., Chandler J., Martin MG.  Comorbities drive outcomes for both malignancy and non-malignancy associated hemophagocytic syndromes.  Presentation ASH - Hematologic Maligancies  9/9/2015.

Jamy O., Giri S., Wiedower E., Johnson B., Nunnery S., Martin MG.  Under recognition of hemophagocytic lymphohistiocytosis in US rural non-teaching hospitals.  Presentation ASH - Hematologic Maligancies  9/9/2015.

Qi, W., Morales, C., Cooke, L.S., Johnson, B., Somer, B, Mahadevan, D.  Dual Inhibition of the Androgen Receptor & PI3K/mTOR Pathways has significant anti-tumor activity in Castration-Resistant Prostate Cancer.  Oncotarget. 2015, Dec 8, pg 41976-87.

Giri, S., Chi, M., Johnson, B., Jamy, O., McCormick, D., Martin, M.  Secondary acute lymphoblastic leukemia is an independent predictor of poor prognosis.  Leuk Res. 2015, Dec.  pg 1342-6. 

Johnson, B. and Johnson, R.  Secondary Hemophagocytic Lymphohistiocytosis (SHLH) in the Context of Newly Diagnosed Philadelphia Positive, CD 20+ B-Cell Acute Lymphoblastic Lymphoma (B-ALL): A Case Report and Brief Review of Literature.  J Cancer Biol Res v3 issue 2  Dec 2015 pg 1061.

Eric Wiedower

E. Wiedower.  Induction of AML with idarubicin, cytarabine, and cladribine.  Presentation at Mayo Clinic Meeting  7/30/2015.

Jamy O., Giri S., Wiedower E., Johnson B., Nunnery S., Martin MG.  Under recognition of hemophagocytic lymphohistiocytosis in US rural non-teaching hospitals.  Presentation ASH - Hematologic Maligancies  7/31/2015.

Johnson, B., Giri S., Nunnery S., Wiedower E., Jamy O., Chandler J., Martin MG.  Comorbities drive outcomes for both malignancy and non-malignancy associated hemophagocytic syndromes.  Presentation ASH - Hematologic Maligancies  7/31/2015.

Wiedower, Giri, Fintel, Prouet, Paulus, Chandler, Martin.  Addition of rituximab to chemotherapy decreased mortality rates of primary surgery for gastric DLBCL without increasing early mortality.  Presentation ASH - Hematologic Maligancies 7/31/2015.

George Yaghmour

O Jamy, S. Nunnery, E. Wiedower, B. Johnson, G. Yaghmour, M. Martin.  Under-Recognition of Hemophagocytic Lymphohistiocytosis in United States' Rural, Non-Teaching Hospitals.  Leuk Lymphoma epub ahead of print. V 18 issue April 2016 pg 1-3

B. McCullar, M. Pandey, G. Yaghmour, F. Hare, K. Patel, M. Stein, R. Feldman, JC Chandler, MG Martin. Genomic landscape of small cell carcinoma of the breast contrasted to small cell carcinoma of the lung.  Breast Cancer Res Treat. 2016 Jul;158(1):195-202.  June 21, 2016.

Michelle Chi

Giri S, Chi M, Johnson B, McCormick D, Jamy O, Bhatt VR, Martin MG.  Secondary acute lymphoblastic leukemia is an independent predictor of poor prognosis.  Leuk Res. 2015 Dec;39(12):1342-6

VanderWalde NA, Chi MT, Hurria A, Galsky MD, Nielsen ME.  Treatment of muscle invasive bladder cancer in the elderly: navigating the trade-offs of risk and benefit.  World J Urol. 2016 Jan;34(1):3-11

Muhammad Mirza
Catherine Gorman Ireland, Muhammad Mudassir Mirza, Alexandria Tran, Jason Claud Chandler, Monika Metzger, Michael Gary Martin, Impact of provider volume on outcomes of patients with Hodgkin lymphoma. J Clin Oncol 34, 2016 (suppl; abstr e18203). 
Sameer Nasir

Smith Giri, MD, Syed Sameer Nasir, MD, Michael Gary Martin MD,  Outcome of Adolescent and young adults with acute myeloid leukemia.  Presentation ASH - Hematologic Maligancies  9/9/2015.

Smith Giri, MD, Syed Sameer Nasir, MD, Michael Gary Martin MD,  Outcome of Adolescent and young adults with acute myeloid leukemia.  Presentation ASH – Annual Meeting  12/5/2015.

Syed Sameer Nasir, MD, Alva B Weir, MD.  ICU Deaths in Advanced Cancer Patients: Reasonable Criteria to Decrease Potentially Inappropriate Admissions and Lack of Benefit of Advance Planning Discussions.  American Journal of Hospice and Palliative Care Medicine.  Dec 2015.

Syed Sameer Nasir, MD; Micheal G Martin MD.  Outcome of Adolescents and Young Adults As Compared to Pediatric Patients with Acute Myeloid and Acute Promyelocytic Leukemia: Real World Data from the SEER Registry.  Presentation at ASCO annual meeting June, 2016.

Syed S Nasir MD; Lee Schwartzberg MD.   Updates on Chemotherapy Induced Nausea and Vomiting.  Journal of Oncology.  May, 2016.

Syed Sameer Nasir, MD.  ICU Deaths in Advanced Cancer Patients: Reasonable Criteria to Decrease Potentially Inappropriate Admissions and Lack of Benefit of Advance Planning Discussions.  TOPS Winner 5/6/2016.

Last Published: Jul 20, 2017